BGP

(redirected from Osteocalcin)
Also found in: Dictionary, Medical, Wikipedia.

BGP

BGP

(1) See also BPG.

(2) (Border Gateway Protocol) The routing protocol that is used to span autonomous systems on the Internet. It is a robust, sophisticated and scalable protocol that was developed by the Internet Engineering Task Force (IETF). BGP4 supports the CIDR addressing scheme, which increased the number of available IP addresses on the Internet. A path vector protocol, BGP was designed to supersede EGP, the original exterior gateway protocol. See autonomous system, CIDR and routing protocol.
References in periodicals archive ?
The researchers believe the osteocalcin is indigenous to these fossils because invertebrates and bacteria do not produce this protein.
Pitavastatin enchanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.
Sufficient vitamin K is also required in order to activate the Gla-protein osteocalcin, which binds tightly to bone minerals to create strong bones.
We also observed mRNA expression of the osteoblastogenic markers BMP-2 and osteocalcin Bmp2 was decreased by 0.
In an attempt to further characterize the spindle cell sarcoma mass, immunohistochemical analysis was performed for osteocalcin and osteonectin.
RT-PCR analysis showed that bone specific proteins including osteopontin and osteocalcin were expressed in the cells.
The bone formation markers in the serum include osteocalcin (OC), alkaline phosphatase (ALP), and procollagen, while bone resorption markers include carboxyterminal telopeptide of type I collagen and in urine as hydroxyproline, collagen type I telopeptide, etc.
Washington, December 12 ( ANI ): Scientists, led by an Indian-origin researcher, have shown for the first time how the little-understood protein osteocalcin plays a significant role in the strength of our bones.
Chapters address various hormones and neuromediators ranging from serotonin to osteocalcin, as well as knowledge about the ability of bone to regulate phosphate metabolism.
The commercial release of the Mouse Sclerostin ELISA serves to expand ALPCO's current bone metabolism portfolio which consists of assays including Human Sclerostin, Human Osteoprotegerin and sRANKL, Mouse/Rat Osteoprotegerin and sRANKL as well as kits specific for Human and Rodent Osteocalcin.